Erie Indemnity (ERIE) Misses Q4 EPS by 1c, Revenue Beats
Tweet
Share
E-mailGet Alerts ERIE Hot Sheet
Price: $248.54 -1.69%
Revenue Growth %: +1.9%
Financial Fact:
Common stock - diluted (in shares): 52.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +1.9%
Financial Fact:
Common stock - diluted (in shares): 52.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Erie Indemnity (NASDAQ: ERIE) reported Q4 EPS of $1.20, $0.01 worse than the analyst estimate of $1.21. Revenue for the quarter came in at $609.3 million versus the consensus estimate of $599.88 million.
For earnings history and earnings-related data on Erie Indemnity (ERIE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
- GE Aerospace to acquire Consolidated Precision in $11.75b deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
